Your browser doesn't support javascript.
loading
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors.
Ohkuma, Toshiaki; Harris, Katie; Cooper, Mark; Grobbee, Diederick E; Hamet, Pavel; Harrap, Stephen; Mancia, Giuseppe; Marre, Michel; Patel, Anushka; Rodgers, Anthony; Williams, Bryan; Woodward, Mark; Chalmers, John.
Affiliation
  • Ohkuma T; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Harris K; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Cooper M; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Grobbee DE; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Hamet P; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Harrap S; Centre de Recherche, Center Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
  • Mancia G; Department of Physiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.
  • Marre M; Istituto Auxologico Italiano, University of Milan-Bicocca, Milan, Italy.
  • Patel A; Hopital Bichat-Claude Bernard, Universite Paris, Paris, France.
  • Rodgers A; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Williams B; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Woodward M; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.
  • Chalmers J; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Clin J Am Soc Nephrol ; 17(8): 1139-1149, 2022 08.
Article in En | MEDLINE | ID: mdl-35896277

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Diseases / Diabetes Mellitus, Type 2 / Gliclazide / Hyperkalemia Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vascular Diseases / Diabetes Mellitus, Type 2 / Gliclazide / Hyperkalemia Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos